BRX-0585

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBRX-0585

Drug Alias NameGLP-1 fusion peptideBRX-0585GLP-1-Tf

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2

ATC CodeN/A